
























































































identifi incipi dementia individu use machin learn and amyloid imag 


labl at sciencedirect 

neurobiolog of age xxx (2017) 1e11 
content list avai 
neurobiolog of age 

journal homepage: www.elsevi .com/locate/neuag 
identifi incipi dementia individu use machin learn 
and amyloid imag 

sulantha mathotaarachchi a,b, tharick A. pascoal a, monica shin a, andrea L. benedet a, 
min Su kang a, thoma beaudri a, vladimir S. fonov b, serg gauthier c,d,e, f, 
pedro rosa-neto a,b,c,d,e, f,*, for the alzheimer’ diseas neuroimag initiative1 

a translat neuroimag laboratory, mcgill univers research centr for studi in age (mcsa), dougla research institute, mcgill university, 
montreal, quebec, canada 
bmcconnel brain imag centre, montreal neurolog institute, mcgill university, montreal, quebec, canada 
cmcgill univers research centr for studi in age (mcsa), dougla research institute, mcgill university, montreal, quebec, canada 
ddougla research institute, mcgill university, montreal, quebec, canada 
edepart of psychiatry, mcgill university, montreal, quebec, canada 
fdepart of neurolog & neurosurgery, mcgill university, montreal, quebec, canada 
a r t i c l e i n f o 

articl history: 
receiv 6 march 2017 
receiv in revis form 20 june 2017 
accept 30 june 2017 

keywords: 
alzheimer’ diseas 
mild cognit impair 
predict 
amyloid 
random forest 
random under sampl 
* correspond author at: translat neuro 
univers research centr for studi in aging, 6875 L 
montreal, québec h4h 1r3, canada. tel.: þ1 514 766- 

e-mail address: pedro.rosa@mcgill.ca (p. rosa-neto 
1 data use in prepar of thi articl be ob 

diseas neuroimag initi (adni) databas (ad 
investig within the adni contribut to the de 
adni and/or provid data but do not particip i 
report. A complet list of adni investig can be 
edu/wp-content/uploads/how_to_apply/adni_acknow 

0197-4580/� 2017 the author(s). publish by elsevi 
http://dx.doi.org/10.1016/j.neurobiolaging.2017.06.027 
a b s t r a c t 

identifi individu destin to develop alzheimer’ dementia within time frame accept for 
clinic trial constitut an import challeng to design studi to test emerg disease-modifi 
therapies. although amyloid-b protein be the core patholog featur of alzheimer’ disease, bio- 
marker of neuron degener be the onli one believ to provid satisfactori predict of 
clinic progress within short time frames. here, we propos a machin learningebas probabilist 
method design to ass the progress to dementia within 24 months, base on the region in- 
format from a singl amyloid positron emiss tomographi scan. importantly, the propos method 
be design to overcom the inher advers imbal proport between stabl and progress 
mild cognit impair individu within a short observ period. the novel algorithm obtain 
an accuraci of 84% and an under-receiv oper characterist curv of 0.91, outperform the 
exist algorithm use the same biomark measur and previou studi use multipl biomark 
modalities. with it high accuracy, thi algorithm have immedi applic for popul enrich 
in clinic trial design to test disease-modifi therapi aim to mitig the progress to 
alzheimer’ diseas dementia. 
� 2017 the author(s). publish by elsevi inc. thi be an open access articl under the CC by-nc-nd 

licens (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
1. introduct 

alzheimer’ diseas be the most common form of dementia, ac- 
count for approxim 60%e80% of the case with alarm 
econom and social cost (pouryamout et al., 2012). It be well un- 
derstood that alzheimer’ diseas pathophysiolog follow a 
imag laboratory, mcgill 
a sall blvd - fbc room 3149, 
2010; fax: þ1 514 888-4050. 
). 
tain from the alzheimer’ 
ni.loni.usc.edu). As such, the 
sign and implement of 
n analysi or write of thi 
found at: http://adni.loni.usc. 
ledgement_list.pdf. 

inc. thi be an open access articl 
gradual cours with patholog develop over decad befor 
symptom onset (braak and braak, 1991; mosconi et al., 2007). thus, 
there be an increas interest to advanc the disease-modifi 
clinic trial to the predementia stage of alzheimer’ diseas 
give the good chanc of obtain tangibl disease-modifi 
effects. thi have be encourag by the identif of bio- 
marker to detect the patholog signatur at the earli stage of the 
diseas (buerger et al., 2006; fagan et al., 2006;mcevoy and brewer, 
2010; morri et al., 2009). however, give the high preval of 
cognit normal elderli individu carri the alzheimer’ 
diseas pathophysiology, accur identifi individu who be 
in the earli stage of alzheimer’ diseas have be a signific 
challenge. thus, the develop of effect clinic trial have be 
sever hamper by not be abl to recruit individu who 
have a high likelihood of develop alzheimer’ diseas (holland 
et al., 2012) within a time period accept to conduct a study. 
under the CC by-nc-nd licens (http://creativecommons.org/licenses/by-nc-nd/4.0/). 

delta:1_given name 
delta:1_surnam 
delta:1_given name 
delta:1_surnam 
delta:1_given name 
delta:1_surnam 
delta:1_given name 
delta:1_surnam 
delta:1_given name 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
mailto:pedro.rosa@mcgill.ca 
http://adni.loni.usc.edu 
http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/adni_acknowledgement_list.pdf 
http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/adni_acknowledgement_list.pdf 
www.sciencedirect.com/science/journal/01974580 
http://www.elsevier.com/locate/neuag 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
http://dx.doi.org/10.1016/j.neurobiolaging.2017.06.027 
http://dx.doi.org/10.1016/j.neurobiolaging.2017.06.027 
http://dx.doi.org/10.1016/j.neurobiolaging.2017.06.027 


S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e112 
identif of effect biomark signatur to determin the 
progress of dementia have be a signific challeng to accu- 
rate predict the short-term clinic progression. It be believ that 
the biomark of neurodegener such a glucos metabol 
and brain atrophi would be the most effective, a the other path- 
olog marker such a brain amyloid-b (ab) deposit and for- 
mation of hyperphosphoryl tau tangl occur year or decad 
befor the symptom onset (jack et al., 2010a,b, 2013). however, 
numer studi base on neurodegen biomark have 
indic a decreas in the abil to predict the clinic progress 
when the observ time be more than 18 months. given that the 
accumul of Ab in the brain be a hallmark characterist of 
alzheimer’ disease, amyloid-bas biomark can be assum to 
provid a good sensit to alzheimer’ diseas patholog over a 
longer observ period (trzepacz et al., 2014). 

studi conduct to evalu the util of amyloid biomark 
have use the cerebrospin fluid (csf) Ab measur due to 
the rel high avail compar with amyloid positron 
emiss tomographi (pet) biomarkers. these studi have often 
combin other csf measur such a tau and p-tau concen- 
tration and magnet reson imag (mri) biomark 
(apostolova et al., 2014; davatziko et al., 2011; hall et al., 2015; 
yang et al., 2012; young et al., 2012) to accommod for the 
limit dimension offer by the csf measurements. however, 
the possibl to region ass alzheimer’ diseas pathophys- 
iolog and the increas avail of amyloid pet imag in large- 
scale age studi have enabl the evalu of thi imag 
biomark a a diagnost tool. 

As the earli detect clinic stage of the trajectori toward 
dementia, mild cognit impair (mci) provid an attract 
point of entri to disease-modifi intervent (markesbery, 
2010). however, not all mci individu carri alzheimer’ diseas 
pathophysiolog and progress to alzheimer’ diseas in an optim 
time frame for clinic trial. thus, identif of biomark sig- 
natur of mci individu on the verg of progress to dementia 
and predict the likelihood of convers have immedi appli- 
cation in disease-modifi clinic trial by includ those in- 
dividu with high likelihood to progress. thi will increas the 
statist power of the clinic trial by reduc fals posit and 
would directli impact the associ costs. furthermore, these in- 
formationwould also provid import prognost inform for 
the patient and their famili to plan and manag treatment and 
care (gelosa and brooks, 2012). 

the predict of the clinic progress to dementia from mci 
phase constitut a challeng due to the consider low number 
of progress mci (pmci) individu compar with the stabl mci 
(smci) individuals, invari creat imbalanc class (pmci and 
smci). In a classif study, if the number of sampl from a class 
(smci) greatli outnumb the other class (pmci), the classifi 
tend to favor the over-representedmajor class (smci) by ignor 
the incorrect predict in theminor class (pmci). thi constitut 
a challeng know a the “class imbal problem” and lead to 
decreas sensit of the prediction, which have be current 
overlook in alzheimer’ diseas research. while there be a num- 
ber of techniqu develop to address thi challenge, such a class 
weight adjusting, oversampl the minor class, and under- 
sampl themajor class (japkowicz and stephen, 2002), the latter 
be identifi to perform the best (seiffert et al., 2008, 2010). random 
under sampl (rus) be a method of under sampling, which will 
train each of it base learner with the full minor class and a 
randomli under sampl major class. By do this, each base 
learner be trainedwith a balanc set of sampl from both pmci and 
smci classes, remov the bia toward ani particular class. 

amyloid pet imag use in the studi be [18f]florbetapir pet 
scan acquir from the alzheimer’ diseas neuroimag 
initi (adni). the studi cohort present a pmci rate of 15.75%, 
similar to the rate present by other cohort studi and com- 
muniti studi (mitchel and shiri-feshki, 2009). thi present the 
aforement class-imbalanc challenge. current studi util 
ru to overcom thi challenge. the novel predict algorithm be 
present a ru random forest (rusrf) and be use to evalu the 
util of amyloid pet a a diagnost tool. 

the present studi aim to evalu the util of amyloid pet 
imag a an earli detect tool for individu in the alzheimer’ 
diseas pathway. specifically, we aim to predict if an mci individu 
will progress to alzheimer’ diseas or remain mci within a time 
period of 24 month base on the amyloid pet measur at 
baseline. We further believ that the propos techniqu can be 
use to complement the multibiomark enrich strategi for 
clinic trial (wolz et al., 2016). 

thi novel techniqu capit on an optim featur 
extract method for amyloid pet, and a method for address 
the class imbal problem in the context of a random forest 
machin learn classifi (breiman, 2001). We further compar 
the perform of rusrf with other widely-us predict al- 
gorithm such a the support vector machin (svm), L1 and L2 
regular logist regression, and random forest. We believ that 
the novel rusrf algorithm will outperform these widely-us 
predict algorithm and that the amyloid pet biomark might 
serv a an import earli diagnost tool in both research and 
clinic environments. 

2. materi and method 

2.1. subject and data acquisit 

data use in the prepar of thi articl be obtain from 
the adni database. adni be launch in 2003 a a public-priv 
partnership, lead by princip investig michael W. weiner, md. 
the primari goal of adni have be to test whether serial mri, 
positron emiss tomographi (pet), other biolog markers, and 
clinic and neuropsycholog assess can be combin to 
measur the progress of mci and earli alzheimer’ disease. 

We select 273 adni-go/2 particip meet the criterion for 
single-domain or multidomain amnest mci and acquir their [18f] 
florbetapir pet, demographic, apoe4 genotyp inform and the 
clinic diagnosiswith the correspondingdiagnosi inform for the 
subsequ 24-month follow-up visit (mean follow-up time: 
24.37 months, standard deviation: 1.51 months). for pet imag pro- 
cess purposes, the match t1-weight mri imag be also 
obtained. the elig criterion of mci be particip with mini- 
mental state examin (mmse) score equal to or great than 24, 
a clinic dementia rate of 0.5, subject and objectivememori loss, 
normal activ of daili living, and the absenc of other neuropsy- 
chiatric disord includ alzheimer’ diseas (petersen, 2003). 

the subject be categor into 2 groups, smci and pmci, 
base on the diagnosi on their follow-up visit. If a subject be 
diagnos to be alzheimer’ diseas in the follow-up visit, that 
subject be categor a pmci, and if the subject remainedmci at 
the 24-month follow-up visit, he or she be categor a smci. Of 
the 273 individu use in the study, onli 43 (15.75%) individu 
be diagnos a probabl alzheimer’ diseas in their follow-up 
visit and be categor a pmci. demograph inform of 
the sampl of individu use in the studi be present in tabl 1. 

2.2. imag process 

the acquir t1-weightedmri imag be process use the 
civet imag process pipelin (ad-dab’bagh et al., 2006; 
zijdenbo et al., 2002), where the imag underw non- 



tabl 1 
demograph of subject includ in the studi and their classif in train 
and test set 

characterist smci pmci 

N (273) 230 43 
age (sd) 71.45 (7.52) 73.25 (7.65) 
male (females) 135 (95) 23 (20) 
education(sd) 16.2 (2.71) 15.86 (2.81) 
apo 4eposit (neg)*** 81 (149) 33 (10) 
mmse (sd)*** 28.22 (1.64) 26.91 (1.87) 
train ðstrainþ (pmci ratio) 161 30 (15.71%) 
test ðstestþ (pmci ratio) 69 13 (15.85%) 

key: mmse, mini-ment state examination; pmci, progress mci. 
***p < 0.05. 

S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e11 3 
uniform correct (sled et al., 1998), brain mask (smith, 
2002), linear and nonlinear registr to the icbm 152 tem- 
plate (fonov et al., 2009; mazziotta et al., 1995) use the anim 
(collin and evans, 1997; collin et al., 1995; robbin et al., 2004) 
imag registr algorithm. download [18f]florbetapir pet 
imag be alreadi preprocess to perform motion correct 
and to acquir uniform spatial resolut accord to the step 
outlin in (online: http://adni.loni.usc.edu/methods/pet-analysis/ 
pre-processing/, accessed: 28-03-2016). the pet imag be then 
regist to the subjects’ own t1-weight mri imag and be 
spatial normal to the icbm 152 template. they be then 
normal for the region intens from the cerebellum gray 
matter and the global white matter to gener [18f]florbetapir pet 
standard uptak valu ratio (suvr) images. 

2.3. subject classif 

two set of subject be gener from the total set of in- 
dividu a train set (strain) and test set (stest; tabl 1). the 
train set be use in the featur select step and train the 
machin learn algorithm, while the test set be use sole to 
evalu the perform of the train machin learn algo- 
rithm. sinc the test set be not use in the featur select step 
or in training, we void ani bia or advers effect from “doubl 
dipping” in the predict of progress to alzheimer’ disease. 
the ratio between the smci and pmci individu be preserv in 
both the train set and the test set. 

2.4. featur select 

To identifi the brain region from where the pet suvr valu 
be read a featur for the predictors, we employ a voxel-wis 
logist regress analysi use the voxelstat (mathotaarachchi 
et al., 2016) toolbox. for each brain voxel, the follow logist 
function be solved: 

In 
� p 
1� p 

� 
¼ b0 þ b1*½18f�florbetapir þ b2*ageþ b3*gender 

þ b4*apoe4 
where p ¼ probabl of progress to alzheimer’ diseas in 
24 months. then, for each voxel, the scale increas in odd (scale 
odd ratio) for one standard deviat (s) increas in [18f]florbe- 
tapir pet suvr be calcul a follows: 

odd ratioscaledðorscaledþ ¼ eb1* 

anatom signific brain region with orscal > 1:5 be 
selectedbasedonexpertopinion, andpetsuvr intens fromthes 
regionswer extract a themeanof a 3�3�3 clusterof voxels. the 
abov region pet suvr intens along with age, gender, and 
apoe4 genotyp statu be fed into the predictor a features. 
2.5. predict 

predict be perform use the novel algorithm rusrf 
base on the random forest classifi (breiman, 2001). the novel 
algorithm us sampl techniqu to trainmultipl random forest 
predictor to calcul the final prediction. the primari goal of the 
present applic be to predict progress to alzheimer’ disease; 
however, the popul contain onli 15.71% pmci individuals. 
thi constitut a class imbal problem with a major smci 
class. In thi case, the predictor tend to be bia to predict the 
major class (smci) and to ignor the misclassif in the 
minor class (pmci) (yen and lee, 2009). To overcom this, the 
novel algorithm util a data sampl techniqu name “random 
undersampling,” where the major class be randomli sampl to 
creat a pseudo train set with equal proport in all the clas- 
ses. thi techniqu be close relat to the rusboost techniqu 
(seiffert et al., 2008); however, the base classifi use in the pre- 
sent studi be random forest and the iter boostingmethod be not 
employ a the random forest classifi us featur bag to 
achiev independ and randomness. 

In summary, rusrf algorithm will train K number of random 
forest predictor with individu pseudo train set with equal 
class distributions. the number of minor class sampl ðnaþ in a 
pseudo train set be equal to the total number of minor class 
sampl in the origin train set. thus, all K random forest pre- 
dictor be train for all the minor class instances. the number 
of major class sampl be calcul to be a fraction ðf Þ high 
than the number of sampl in the minor class. the final prob- 
abil predict be calcul a the mean probabl across all the 
K random forests, and the final predict be calcul a the final 
probabl predict great than 0.5. 

the implement of the rusrf algorithmwa do in python 
program languag use the random forest implement in 
the scikit-learn librari (online: http://scikit-learn.org/stable/, 
accessed: 28-04-2016). 
2.6. perform evalu and comparison 

the rusrf algorithm have 2 primari paramet to be optim 
base on the application, which be the number of random forest 
predictor and the number of decis tree in each of the random 
forest predictor. To estim the best combin of these 2 pa- 
rameters, we employ a nest cross-valid techniqu 
(huttunen et al., 2012; moradi et al., 2015). the outer cross- 
valid step divid the train set ðstrainþ in to 10 subset 
ðsitrain; i ¼ 1.10þ preserv the class ratio of the origin popu- 
lation (stratifi cross validation). In each train step i, sitrain be 
subdivid (use stratifi cross validation) into 10 subset 
ðsijtrain; j ¼ 1.10þ and be pass to rusrf algorithm with a tupl 
of paramet (number of random forest predictors, number of 
tree in each predictor) select from a grid of paramet combi- 
nation for training. the best set of paramet be select base 
on the auc from the intern 10-fold cross validation. the perfor- 
manc of the predictor be then evalu base on the auc, ac- 
curaci (number of correct classif divid by the total 
number of sampl [in stest]), F1 score (harmon mean of precis 
and recall), sensit (number of correctli classifi pmci subject 
divid by the total pmci subjects), and specif (number of 
correctli classifi smci subject divid by the total smci subjects) 
for the origin test set ðstestþ. these valu be calcul base 
on the predict of each outer cross-valid step i, on the 
test set ðstestþ. By evalu the perform base on the 
origin test set ðstestþ, we record the true gener abil of 
the rusrf predictor. 

http://adni.loni.usc.edu/methods/pet-analysis/pre-processing/ 
http://adni.loni.usc.edu/methods/pet-analysis/pre-processing/ 
http://scikit-learn.org/stable/ 


fig. 1. summari of the step follow to train the rusrf algorithm to predict the progress of dementia. abbreviations: mci, mild cognit impairment; roc, receiv oper 
characteristic; rusrf, ru random forest. 

S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e114 
To examin the perform gain from the rusrf predictor, we 
train 4 other widely-us classifi such a svm, logist 
regress with L1 regularization, logist regress with L2 reg- 
ularization, and random forest (breiman, 2001) use the same set 
of featur and compar with the perform of rusrf. evalu- 
ate the optimum paramet and the perform for these 
widely-us classifi be also do use a nest cross- 
valid a describ above. mcnemar’ c2 test be perform 
to compar each of the classifi against random predictors. the 
random predictor be develop by train each of the classi- 
ficat algorithm with a randomli permut train set to 
disrupt the relationship between the class label and input fea- 
tures. furthermore, a pair t-test be perform to compar auc 
and F1 score of the rusrf predictor against the other 4 predictors, 
while mcnemar’ c2 test be use to compar the sensit and 
specificity. however, the overal accuraci of each predictor be not 
use a a measur of comparison becaus it can misinterpret the 
perform when the sampl have imbalanc class probabilities. 
the result p valu be bonferroni adjust to correct for 
multipl comparisons. the classif analysi be carri out in 
python program languag use the scikit-learn librari and 
the statist analysi be carri out use the R program 
language. 

In a binari classification, the random forest algorithm perform 
implicit featur select base on the paramet call “gini 
importance” (breiman, 2001), which be calcul a the accumu- 
late decreas in “gini impur iðtþ”. thi be defin as; 
iðtþ ¼ 1� p20 � p21. here pk ¼ nkn , which be the fraction of the nk 
sampl from class k ¼ f0; 1g out of the total n sampl at a node t 
in a binari decis tree in random forest. the decreas in gini 
impur result from split the node by a threshold sa on 
variabl a, and send the sampl to 2 subnodes, tl and tr , and be 
calcul a D iðtþ ¼ iðtþ � pliðtlþ � priðtrþ, where pl ¼ nln and 
pr ¼ nrn , the rel sampl fraction at node tl and tr . the opti- 
mum split be then determined, which result in the maximum 
decreas in gini impur at node t. the accumul of these 
decreas in gini impur for all node t in all tree T in the forest, 
be know a the gini import ðigþ for variabl a. 

igðaþ ¼ 
X 
T 

X 
t 

diaðt; TÞ 

thi measur indic how often a variabl be use for a split 
and how larg it discrimin power be in the classif study. 
In the rusrf algorithm, the mean of thi measur across all the 
random forests, K , be use a the measur of featur import for 
variabl a. 

importanceðaþ ¼ 1 
K 

X 
K 

X 
T 

X 
t 

diaðt; t;kþ 

step follow in the present studi be summar in fig. 1. 

3. result 

demograph inform of the individu includ in thi 
studi be summar in tabl 1. Of the 273 individuals, 43 (15.75%) 
be diagnos with probabl alzheimer’ diseas after the 24- 
month follow-up and be categor a pmci. 

voxel-wis logist regress analysi result in a scale odd 
ratio map with the high valu in the orbitofront cortex, mid 
frontal cortex, mid tempor cortex, tempor occipit junction, 
posterior cingul cortex, angular gyrus, precuneus, putamen, and 



fig. 2. region with the high odd ratio values. (1) mid frontal cortex, (2) angular gyrus, (3) posterior cingul cortex, (4) orbitofront cortex, (5) precuneus, (6) tempor 
occipit junction, (7) mid tempor cortex, (8) putamen, and (9) nucleu accumben be indicated. 

S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e11 5 
the nucleu accumben (fig. 2). the suvr valu from bilater 
brain region be extract a describ abov and subsequ 
averag to be use a region suvrs. these region suvr valu 
be then use a featur on the predictor togeth with age, 
gender, and apoe4 gene status. 

predict perform from the 5 predictor be show in 
tabl 2. the rusrf predictor have the high predict perfor- 
manc for both smci and pmci individu base on the averag 
area under the receiv oper characterist curv (auc) (0.906 
[�0.009]) and F1 score (0.583 [�0.044]). the rusrf auc score be 
significantli differ from both the svm and L2 logist regress 
at p < 0.0025 and from random forest at p < 0.0125. furthermore, 
the rusrf F1 score be significantli differ from svm at p< 0.0025 
and from L2 logist regress at p < 0.0125. the sensit of the 
rusrf predictor onli differ from the svm predictor at p < 0.025. 
the rusrf specif be differ from L2 logist regress at p 
< 0.0125 and from svm, L1 logist regression, and random forest at 
p < 0.025. the p valu threshold use here for statist signifi- 
canc be bonferroni adjust for multipl comparisons. 

accord to mcnemar’ c2 test (tabl 2), onli the rusrf pre- 
dictor show a statist signific differ with the random 
predictor at p < 0.01. both regular logist regress predictor 
be significantli differ at p < 0.1. however, the random forest 
predictor and the svm predictor be not significantli differ 
from the random predictor. the c2 statist for the svm predictor 
cannot be calcul a the output from the predict from both 
svm and the random predictor be identical. the svm predict 
for each test case, which be calcul a the mean of the pre- 
diction from all 10 iter be 0. thi result in an exagger 
accuraci of 84.15% (all true 0 case correctli predictedespecif 
of 100%). 

fig. 3A show the receiv oper characterist (roc) curv 
for the 4 predictor with their respect auc values. the roc curv 
for the novel rusrf predictor domin the other curv with an 
area of 0.91, follow by the L1 logist predictor, random forest 
predictor, and the L2 logist predictor. the auc <0.5 for the svm 
predictor (tabl 2) indic that the svm predictor be a predictor 
for the smci class but not for the pmci class. 

the rel featur import from the novel rusrf predictor 
be show in fig. 3b. the most import featur indic the brain 
region with the high contribut to predict the pmci class. Ab 
accumul measur by [18f]florbetapir pet suvr in the tem- 
poral occipit junction, mid tempor cortex, mid frontal cortex, 
and precuneu be the most import featur follow by the 
accumul in other brain region and age, gender, and apoe4 
gene status. the featur import from the random forest clas- 
sifier indic the same 4 region to be the most import fea- 
ture (supplementari tabl 1). 

4. discuss 

We have present a novel algorithm for predict the pro- 
gression from mci to alzheimer’ diseas dementia use baselin 
amyloid pet measurements. the novel rusrf algorithm us the 
random forest classifi a it base classifi along with advanc 
data sampl techniqu to overcom inher problem of the 
data sampl to improv the predict accuracy. thi algorithmwa 
show to provid advantag a demonstr by high auc and 
F1 score when compar with the other widely-us predict 
algorithm such a svm, regular logist regression, and 
random forest. furthermore, our preliminari data suggested, that 
thi algorithm could perform compar to themethod employ 
use mri, fdg pet, csf biomarkers, and their combin 
(tabl 3). It be import to emphas that the evalu of the 
predict algorithms, employ a complet independ test 
sampl which be never use in train or featur select steps. 
thi method of evalu resembl the expect outcom in an 
applic (clinic and research) environment, which can be 
consid encourag to be use for the earli diagnosi of alz- 
heimer’ disease. 

use the rusrf algorithm, we obtain auc and F1 score of 
0.906 (0.009) and 0.583 (0.044), respectively, for the independ 
test set. generally, the progress to alzheimer’ diseas de- 
mentia of an mci popul within 24 month lie around 16.2% 
(mitchel and shiri-feshki, 2009). thus, in a predict study, the 
pmci class (the subset of individu progress to alzheimer’ 
disease) be expect to lie close to the same proportion, creat 
imbalanc classes. If the method to overcom thi challeng be 
not involved, the predict algorithm will ignor the error in the 
minor class (japkowicz and stephen, 2002). thi can result in 
exagger accuracies, a the predictor can be bia toward the 
major class, but it can also result in low sensit for the 



tabl 2 
summari of the perform of the predictor used. the statist signific be measur compar with the rusrf predictor 

predictor auc accuraci F1 score sensit specif vs. random predictor mcnemar’ c2 p 

svm 0.436 (0.24)*** 0.834 (0.023) 0.091 (0.193)*** 0.1 (0.212)* 0.972 (0.061)* NA 
L1 logist 0.874 (0.047) 0.752 (0.043) 0.523 (0.051) 0.846 (0.051) 0.735 (0.046)* 8.1990e�02* 

L2 logist 0.871 (0.007)*** 0.751 (0.02) 0.522 (0.023)** 0.854 (0.024) 0.732 (0.023)** 6.7250e�02* 

random forest 0.872 (0.03)** 0.89 (0.014) 0.514 (0.076) 0.369 (0.071) 0.988 (0.009)* 3.7110e�01 

rusrf 0.906 (0.009) 0.84 (0.012) 0.583 (0.044) 0.708 (0.079) 0.865 (0.007) 3.8670e�04*** 

across these methods, rusrf have the best auc and F1 score. 
key: auc, area under the curve; mmse, mini-ment state examination; pmci, progress mci; rusrf, ru random forest; svm, support vector machine. 
*p < 0.025, **p < 0.0125, and ***p < 0.0025. 

S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e116 
minor class. In the present study, pmci individu be onli 
15.75% of the sample. therefore, compar the predict accuraci 
base on the overal accuraci will lead to incorrect conclus due 
to the advers bia toward themajor class (smci). In other words, 
a classifi predict smci, regardless of the input features, will 
result in 84.25% overal accuraci a there will onli be 15.75% 
incorrect predict (pmci individu predict a smci; 0% ac- 
curaci in pmci class). To thi regard, we have exclud the overal 
accuraci a a measur to compar predictor use in thi study; 
however, we usedmcnemar’ c2 test to compar the sensit and 
the specificity. It be import to mention that most of the studi 
conduct to predict the progress of alzheimer’ diseas de- 
mentia from mci have not consid whether their sampl 
repres the imbalanc proport of the popul (see 
tabl 3). thi can lead to inconsist result when the studi be 
use in a clinic set a the model have be train and test 
on a heighten represent of the pmci population. given that 
the popul use in the present studi be a closer represent 
of the mci population, the result of the studi can be consid 
transfer to the clinic use in earli diagnosis. 

mcnemar’ c2 test be use to evalu the statist signific 
differ between each predictor use in the studi (rusrf, svm, 
regular logist regression, and random forest) against a 
random predictor. the random predictor be creat by train 
each of the algorithm (rusrf, svm, regular logist regression, 
and random forest) with a randomli permut set of featur 
deriv from the origin train set. By do this, the relationship 
between the featur and the class be complet disrupt and 
the predictor be train to learn a random pattern. A statist 
signific differ from a random predictor be onli observ in 
the rusrf predictor at p < 0.01, indic that the novel algorithm 
be abl to learn the classif pattern with a signific dif- 
ferenc to a randomli train classifier. both regular logist 
regress algorithm show differ at p < 0.1, indic a 
trend. thi may be due to the limit number of sampl use in the 
test set and the skew proport of smci and pmci in- 
dividuals. however, neither the random forest predictor nor the 
svm predictor show a signific differ from a random 
predictor, indic their failur to learn the predict relation- 
ship from the train set. 

mcnemar’ c2 test and pair t-test be use to compar the 
perform of the rusrf algorithm with other predict algo- 
rithms. the auc score can be consid a singl metric for classifi 
perform when deal with highli unequ sampl size 
(eskildsen et al., 2013). the rusrf algorithm achiev the high 
auc score and be significantli differ to both svm and L2 logist 
regress at p < 0.0025 and to random forest at p < 0.0125. 
although the auc of rusrfwa nomin high than the auc of L1 
logist regression, it be not significantli different. however, the 
standard deviat of the auc in L1 logist regress be consid- 
erabl great than that of rusrf. thi indic that the perfor- 
manc of the L1 logist regress be more sensit to the nois 
present in the input featur (frome et al., 2007; Fu et al., 2006), 
which can lead to inconsist result in a clinic set when use 
in earli diagnosis. We also use the F1 score to compar the pre- 
dictor perform a it consid both the precis and recal to 
construct the metric. the rusrf predictor achiev the high F1 
score and be significantli differ from svm at p < 0.0025 and 
from L2 logist regress at p < 0.0125. the F1 score of rusrf be 
nomin high compar with both L1 logist regress and 
random forest but be not significant. however, in the case of 
random forest, thi can be due to the high precis result from a 
high specif evenwith a low sensit value. It be import to 
mention that the F1 score can be influenc by skew class pro- 
portion (jeni et al., 2013) and need to be consideredwhen use a a 
performancemeasure. both auc and F1 score be compar use 
pair t-test with bonferroni adjust threshold for inference. 

compar the sensit and specif between rusrf and 
the other predictor be perform use the mcnemar’ c2 test. 
the sensit of the rusrf predictor be significantli high onli 
when compar to the svm predictor. thi can be greatli due to the 
low number of pmci individu (n ¼ 13) in the test set, a the 
statist be calcul consid onli the pmci individuals. 
furthermore, both L1 and L2 logist regress predictor be 
nomin high than the sensit of rusrf. however, give the 
number of pmci individuals, misclassif of even a singl in- 
dividu can caus the sensit metric to fluctuat substantially. 
although the specif of both the svm and the random forest 
predictor be high than rusrf, their sensit be not 
accept for ani clinic or research use. among the rusrf and 
logist regress predictors, rusrf achiev the high speci- 
ficiti and be significantli differ from L2 logist regress at p 
< 0.0125 and from L1 logist regress at p < 0.025. although the 
svm classifi be use wide in mani applications, our analysi 
indic that, at it current configurationwith a radial basi kernel, 
it produc a veri low sensit and be not suitabl in identifi 
pmci individuals. however, the svm classifi can be train with a 
number of kernel function such a the polynomi kernel func- 
tions, sigmoid kernel functions, and linear kernel functions, and thi 
would lead to increas sensit and overal classif 
performance. 

direct comparison with other similar studi conduct to 
ass the predict capabl of amyloid imagingebas bio- 
marker cannot be perform due to a number of reason (see 
summar comparison in tabl 3). most studi (brück et al., 
2013; hatashita and yamasaki, 2013; jack et al., 2010a,b; wolk 
et al., 2009) have use [11c]pib pet a the imag biomarker, a 
it be commonli use befor the introduct of [18f]-base radio 
ligand (except the author of (waragai et al., 2009), have use [11c] 
bf-227 pet). both teipel et al. (2015) and schreiber et al. (2015) 
have use [18f]florbetapir pet; however, teipel et al. (2015) have 
use both [18f]fdg pet and mri biomark in combin with 
amyloid pet a the input featur for the predictor. furthermore, 
studi with similar observ period (brück et al., 2013; ewer 
et al., 2012; jack et al., 2010a,b; waragai et al., 2009) have re- 
port much high progress rates. these increas rate may 



fig. 3. (a) roc curv for the 4 predictor with correspond auc values. the roc curv be plot for the median perform predictor from the cross-valid steps. the 
high auc be record with the curv for rusrf. (b) rel featur import from the rusrf predictor. the tempor occipit junction, the mid tempor cortex, the mid 
frontal cortex, and the precuneu show the high import for the prediction. abbreviations: auc, area under the curve; roc, receiv oper characteristic; rusrf, ru 
random forest. 

S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e11 7 



tabl 3 
summari of sever previou studi perform to predict progress to alzheimer’ diseas dementia from mci 

studi data valid result (acceaccuracy, senesensitivity, 
speespecificity) 

waragai et al., 2009 total: 13, smci: 7, pmci: 6 
follow-up: 27 mo 
[11c]bf-227 pet 

No valid sen: 100%, spe: 71% 

hatashita and yamasaki, 2013 total: 68, smci: 38, pmci: 30 
follow-up: 19.2 mo 
[11c]pib pet 

No valid sen: 97%, spe: 42% 

brück et al., 2013 total: 29, smci: 12, pmci: 17 
follow-up: 24 mo 
[11c]pib pet and [18f]fdg pet 

No valid sen: 88%, spe: 71% 

wolk et al., 2009 total: 26, smci: 21, pmci: 5 
follow-up: 21.2 mo 
[11c]pib pet 

No valid sen: 100%, spe: 55% 

ewer et al., 2012 total: 131, smci: 56, pmci:75 
follow-up: 24 mo 
[11c]pib pet 

No valid sen: 81%, spe: 83% 

jack et al., 2010a,b total: 218, smci: 125, pmci: 93 
follow-up: 24 mo 
[11c]pib pet 

No valid sen: 50%, spe: 81% 

schreiber et al., 2015 total: 401, smci: 340, pmci: 61 
follow-up: 19.2 mo 
[18f]florbetapir pet 

No valid sen: 87%, spe: 50% 

teipel et al., 2015 total: 127, smci: 88, pmci: 39 
follow-up: 17.3 mo 
[18f]florbetapir pet, [18f]fdg pet and mri 

cross valid acc: 72% 
sen: 30%, spe: 90% 
auc: 0.70 

moradi et al., 2015 total: 264, smci: 100, pmci: 164 
follow-up: 0e36 mo 
mri and cognit 

cross valid acc: 82% 
sen: 87%, spe: 74% 
auc: 0.90 

misra et al., 2009 total: 103, smci: 76, pmci: 27 
follow-up: 0e36 mo 
mri 

cross valid acc: 75%e80% 
auc: 0.77 

davatziko et al., 2011 total: 239, smci: 170, pmci: 69 
follow-up: 0e36 mo 
mri and csf 

cross valid acc: 62% 
auc: 0.73 

Ye et al., 2012 total: 319, smci: 177, pmci: 142 
mri, genet and cognit measur 

cross valid auc: 0.86 

zhang and shen, 2012 total: 88, smci: 50, pmci: 38 
follow-up: 0e24 mo 
mri, [18f]fdg pet and csf 

cross valid acc: 78% 
sen: 79%, spe: 78% 
auc: 0.77 

gaser et al., 2013 total: 195, smci: 62, pmci: 133 
follow-up: 0e36 mo 
mri 

independ test set auc: 0.78 

cuingnet et al., 2011 total: 210, smci: 134, pmci: 76 
follow-up: 0e18 mo 
mri 

independ test set acc: 67% 
sen: 62%, spe: 69% 

eskildsen et al., 2013 total: 388, smci: 227, pmci: 161 
follow-up: 0e48 mo 
mri 

cross valid auc: 0.71a 

wolz et al., 2011 total: 405, smci: 238, pmci: 167 
follow-up: 0-48 moth 
mri 

cross valid acc: 68% 
sen: 67%, spe: 69% 

chupin et al., 2009 total: 210, smci: 134, pmci: 76 
follow-up: 0e18 mo 
mri 

independ test set acc: 64% 
sen: 60%, spe: 65% 

cho et al., 2012 total: 203, smci: 131, pmci: 72 
follow-up: 0e18 mo 
mri 

independ test set acc: 71% 
sen: 63%, spe: 76% 

coupé et al., 2012 total: 405, smci: 238, pmci: 167 
follow-up: 0e48 mo 
mri 

cross valid acc: 74% 
sen: 73%, spe: 74% 

westman et al., 2012 total: 318, smci: 256, pmci: 62 
follow-up: 0e12 mo 
mri 

cross valid acc: 59% 
sen: 74%, spe: 56% 

querb et al., 2009 total: 122, smci: 50, pmci: 72 
follow-up: 0e24 mo 
mri 

cross valid acc: 73% 
sen: 75%, spe: 69% 

koikkalainen et al., 2011 total: 369, smci: 215, pmci: 154 
follow-up (mean): 18.1 mo 
mri 

cross valid acc: 72% 
sen: 77%, spe: 71% 

retico et al., 2015 total: 302, smci: 166, pmci: 136 
follow-up: 0e24 mo 
mri 

independ test set acc: 66% 
sen: 70%, spe: 62% 
auc: 0.71 

S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e118 



tabl 3 (continu ) 

studi data valid result (acceaccuracy, senesensitivity, 
speespecificity) 

doyl et al., 2014 total: 226, smci: 164, pmci: 62 
follow-up: 0e12 mo 
mri 

independ test set (differ cohort) acc: 82% 
sen: 81%, spe: 72% 
auc: 0.81 

lebedev et al., 2014 total: 139, smci: 16, pmci: 123 
follow-up: 0e24 mo 
mri 

independ test set acc: 82% 
sen: 83%, spe: 81% 
auc: 0.83 

thi studi total: 263, smci: 230, pmci: 43 
follow-up: 24 mo 
[18f]florbetapir pet 

independ test set acc: 84% 
sen: 71%, spe: 87% 
auc: 0.91 

key: csf, cerebrospin fluid; mri, magnet reson imaging; pmci, progress mci; smci, stabl mci. 
a follow-up period match to present study. 

S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e11 9 
be due to the lownumb of subject includ (waragai et al., 2009) 
by special memori clinic (brück et al., 2013) and the low 
baselin mini-ment state examin score report 
(brück et al., 2013; ewer et al., 2012; jack et al., 2010a,b; waragai 
et al., 2009). 

nevertheless, these studi except for teipel et al. (2015) have 
not use ani model evalu technique, such a cross validation, 
to ass how their model will gener to an independ data 
set, which be of paramount import to be success use a an 
earli diagnosi tool in a clinic environment. We obtain a high 
overal accuracy, auc, and sensit compar with the accuraci 
report by teipel et al. (2015). the low sensit valu report 
in teipel et al. (2015) may be due the low proport of pmci 
individu includ in the study, lead to a bia toward the 
major smci group. the novel algorithm introduc in thi studi 
compens for thi “imbalanc class problem” by use data 
sampl techniqu a mention earlier. 

compar with sever previou studi use not onli Ab 
petebas biomarkers, the algorithm introduc here seem 
promis with a record averag auc of 0.906 for an independ 
test set (accuracy: 0.84; sensitivity: 0.708; and specificity: 0.865). 
often, studi use perform measur (auc, accuracy, sensi- 
tivity, and specificity) base onli on cross validation; however, thi 
make the predict model bia toward the data set use a all 
the sampl be use for train at some point in the analysis. the 
present studi us a complet independ test set to evalu 
the true gener capabl of the model presented. the in- 
depend test set be not use in the featur extract step or 
the model train steps. By evalu the perform of the 
predict model base on a complet independ test set, 
we can retriev the true expect perform of the model when 
use in a clinic environ a an earli diagnost tool. the 
gener capabl can be further improv by train the 
model on data acquir from multipl cohorts, a use a test set 
from the same cohort can add bia to the predict model. 

the most import characterist of the present studi be it 
abil to overcom the inher imbal of proport between 
pmci and smci individu and perform compar or even 
good than the previou studies. studi conduct by cho et al. 
(2012), davatziko et al. (2011), misra et al. (2009) and teipel 
et al. (2015) use cohort with imbalanc proport similar to 
the present studi to train their predictionmodels, which result in 
low sensit score and low auc values. 

anoth import outcom from the present studi be the 
rel predict capabl of the investig brain region 
(fig. 3b) base on Ab retention. our studi indic that the 4 brain 
regions, the tempor occipit junction, mid tempor cortex, mid 
frontal cortex and precuneu to have the high predict ability. 
other studi conduct with Ab petebas biomark also 
identifi similar region to have the high differ between 
individu progress to alzheimer’ diseas and smci individu 
(brück et al., 2013; koivunen et al., 2011; teipel et al., 2015). these 
region be know to show Ab deposit in rel late stage 
of the cours of alzheimer’ disease. thi agre with the idea that 
the region with earli deposit of Ab such a the posterior 
cingul cortex, alreadi reach a plateau in the mci stage, add 
littl inform to discrimin individu progress to alz- 
heimer’ disease, wherea region with late build-up be more 
relev in discrimin stabl and progress mci individuals. 
interestingly, the featur select techniqu identifi subcort 
structur such a the putamen and the nucleu accumben to be 
use a featur for classification. It be worth to emphas that 
patient with AD have show increas deposit of Ab in these 
subcort brain region occur late in the diseas spectrum 
(ishibashi et al., 2014). furthermore, these region receiv pro- 
jection from differ prefront sub-regions, mainli from the 
medial prefront cortex (ferri et al., 2000; ongür and price, 2000), 
and their associ with behavior characterist and cognit 
perform be well know (de jong et al., 2012; diekhof et al., 
2012). when evalu the brain Ab deposition, the consensu of 
the field of alzheimer’ diseas be to use the averag deposit 
from the brain region characterist of alzheimer’ disease. how- 
ever, thi method averag the Ab deposit in brain region which 
accumul in differ stage of alzheimer’ disease, and will 
result in a suboptim discrimin capabl compar with the 
method introduc in the articl (see supplementari materi for 
result of rusrf perform with averag brain Ab deposition). 
identifi the rel import of Ab deposit in variou 
brain region provid mani benefit to research studi of anti- 
amyloid agent to evalu the treatment’ effect in prevent or 
slow the progress to alzheimer’ disease. 

It be import to mention sever limit of the present 
study. ani alzheimer’ diseas studi involv in vivo data suffer 
from the inher uncertainti of the diagnosi (eskildsen et al., 
2013). thi be becaus the diagnosi of alzheimer’ diseas can 
onli be confirm with autopsi data. therefore, ani clinic diag- 
nosi will alway be “probabl alzheimer’ disease.” It be estim 
that around 10% of thi “probabl alzheimer’ disease” diagnosi 
can be mislabel “lewi bodi disease” or “frontotempor de- 
mentia” (ranginwala et al., 2008). thus, the pattern learnt by the 
predictor might not be specif to alzheimer’ disease; however, 
thi have be partial address by use an alzheimer’ dis- 
easeespecif biomark such a Ab pet compar with a gener 
neurodegen biomark such a mri or glucos metabolism. 

It be import to emphas that the popul includ in thi 
analysi repres a select group of amnest mci individu 
motiv to particip in a dementia study, a such, for reason 
relat to the studi inclus criterion these individu may not 
repres the gener mci population. therefore, it would be highli 
desir to replic our find in a population-bas cohort. 



S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e1110 
furthermore, the predictor present here be bia to the [18f] 
florbetapir pet acquisit protocol follow by adni, a the 
train and test be do use onli the data acquir from the 
adni database. hence, clinic implement of the present 
studi will still requir addit reliabl assess by train 
the predictor use multipl acquisit protocol to increas the 
robust of the prediction. similarly, the featur extract step 
includ identifi brain region with a scale odd ratio abov 
1.5, base on the expert opinion. the rational behind thi step be 
to select the anatom signific brain region with an increas 
of odd for develop alzheimer’ diseas of 50% for each 1 stan- 
dard deviat increas of suvr. however, thi step can add bia 
toward the subject opinion of the expert and can be avoid by 
select brain region base on the opinion of multipl expert or 
by use an autom clusterebas technique. furthermore, due 
to the comput cost of perform multipl voxel-wis lo- 
gistic regress analyses, the featur select techniqu employ 
a singl voxel-wis logist regress analysi includ all the 
subject (exclud the one use a the final test dataset). how- 
ever, the stabil of the identifi region can be further increas 
by employ an undersampl techniqu in identifi the 
features. 

In conclusion, we present a novel algorithm to predict the pro- 
gression to alzheimer’ diseas dementia within mci individu 
base on their Ab pet measurements. the predictor present here 
achiev a high rate of accuraci with an auc of 0.906 for an in- 
depend test set. the novel algorithm overcom the inher 
imbal of proport between stabl and pmci see in a pop- 
ulat of mci individuals, make it ideal suit for a clinic 
environ a an earli diagnost tool. demonstr of such a 
tool use the data present in the current articl can be found at 
http://predictalz.tnlmcgill.ca/predictalz_amy. 

disclosur statement 

the author have no actual or potenti conflict of interest. 

acknowledg 

data collect and share for thi project be fund by the 
adni (nation institut of health grant u01 ag024904) and dod 
adni (depart of defens award number w81xwh-12-2- 
0012). adni be fund by the nation institut on aging, the na- 
tional institut of biomed imag and bioengineering, and 
through gener contribut from the following: abbvie, alz- 
heimer’ association; alzheimer’ drug discoveri foundation; 
araclon biotech; bioclinica, inc; biogen; bristol-my squibb 
company; cerespir, inc; eisai inc; elan pharmaceuticals, inc; eli lilli 
and company; euroimmun; F. hoffmann-la roch ltd and it 
affili compani genentech, inc; fujirebio; GE healthcare; ixico 
ltd; janssen alzheim immunotherapi research & development, 
llc; johnson & johnson pharmaceut research & develop 
llc; lumosity; lundbeck; merck & co, inc; meso scale diagnostics, 
llc; neurorx research; neurotrack technologies; novarti phar- 
maceut corporation; pfizer inc; piram imaging; servier; 
takeda pharmaceut company; and transit therapeutics. the 
canadian institut of health research also provid fund to sup- 
port adni clinic site in canada. privat sector contribut be 
facilit by the foundat for the nation institut of health 
(www.fnih.org). the grante organ be the northern california 
institut for research and education, and the studi be coordin 
by the alzheimer’ diseas cooper studi at the univers of 
california, san diego. adni data be dissemin by the labo- 
ratori for neuro imag at the univers of southern california. 
thi work be support by the canadian institut of health 
research (cihr) [mop-11-51-31], canadian consortium of neuro- 
degener and aging, the alan tiffin foundation, the alzheimer’ 
associ [nirg-12-92090, nirp-12-259245], the fond de 
recherch du québecesanté (p-rn), and the centr for studi on 
prevent of alzheimer’ diseas (stop-ad centre). 
appendix A. supplementari data 

supplementari data associ with thi articl can be found, in 
the onlin version, at http://dx.doi.org/10.1016/j.neurobiolaging. 
2017.06.027. 
refer 

ad-dab’bagh, y., einarson, d., lyttelton, o., muehlboeck, j.s., mok, k., ivanov, o., 
vincent, r.d., lepage, c., lerch, j., fombonne, e., evans, a.c., 2006. the civet 
image-process environment: a fulli autom comprehens pipelin for 
anatom neuroimag research. in: corbetta, M. (ed.), proceed of the 
12th annual meet of the human brain map organization. neuroimage, 
florence, italy. 

apostolova, l.g., hwang, k.s., kohannim, o., avila, d., elashoff, d., jack, c.r., shaw, l., 
trojanowski, j.q., weiner, m.w., thompson, p.m., 2014. apoe4 effect on auto- 
mat diagnost classifi for mild cognit impair and alzheimer’ 
disease. neuroimag clin. 4, 461e472. 

braak, h., braak, e., 1991. neuropatholog stage of alzheimer-rel changes. 
acta neuropathol. 82, 239e259. 

breiman, l., 2001. random forests. mach. learn 45, 5e32. 
brück, a., virta, j.r., koivunen, j., koikkalainen, j., scheinin, n.m., helenius, h., 

någren, k., helin, s., parkkola, r., viitanen, m., rinne, j.o., 2013. [11c]pib, [18f] 
fdg and MR imag in patient with mild cognit impairment. eur. J. nucl. 
med. mol. imag 40, 1567e1572. 

buerger, k., ewers, m., pirttilä, t., zinkowski, r., alafuzoff, i., teipel, s.j., 
debernardis, j., kerkman, d., mcculloch, c., soininen, h., hampel, h., 2006. csf 
phosphoryl tau protein correl with neocort neurofibrillari pathol- 
ogi in alzheimer’ disease. brain 129, 3035e3041. 

cho, y., seong, j.-k., jeong, y., shin, s.y., 2012. individu subject classif for 
alzheimer’ diseas base on increment learn use a spatial frequenc 
represent of cortic thick data. neuroimag 59, 2217e2230. 

chupin, m., gérardin, e., cuingnet, r., boutet, c., lemieux, l., lehéricy, s., benali, h., 
garnero, l., colliot, o., 2009. fulli automat hippocampu segment and 
classif in alzheimer’ diseas and mild cognit impair appli on 
data from adni. hippocampu 19, 579e587. 

collins, d.l., evans, a.c., 1997. animal: valid and applic of nonlinear 
registration-bas segmentation. int. J. pattern recognit. artif. intell. 11, 
1271e1294. 

collins, d.l., holmes, c.j., peters, t.m., evans, a.c., 1995. automat 3-d model-bas 
neuroanatom segmentation. hum. brain mapp. 3, 190e208. 

coupé, p., eskildsen, s.f., manjón, j.v., fonov, v.s., collins, d.l., 2012. simultan 
segment and grade of anatom structur for patient’ classification: 
applic to alzheimer’ disease. neuroimag 59, 3736e3747. 

cuingnet, r., gerardin, e., tessieras, j., auzias, g., lehéricy, s., habert, m.-o., 
chupin, m., benali, h., colliot, o., 2011. automat classif of patient with 
alzheimer’ diseas from structur mri: a comparison of ten method use 
the adni database. neuroimag 56, 766e781. 

davatzikos, c., bhatt, p., shaw, l.m., batmanghelich, k.n., trojanowski, j.q., 2011. 
predict of mci to AD conversion, via mri, csf biomarkers, and pattern 
classification. neurobiol. age 32, 2322.e19e2322.e27. 

de jong, l.w., wang, y., white, l.r., yu, b., van buchem, m.a., launer, l.j., 2012. 
ventral striatal volum be associ with cognit declin in old people: a 
popul base mr-study. neurobiol. age 33, 424.e1e424.e10. 

diekhof, e.k., kaps, l., falkai, p., gruber, o., 2012. the role of the human ventral 
striatum and the medial orbitofront cortex in the represent of reward 
magnitude? An activ likelihood estim meta-analysi of neuroimag 
studi of passiv reward expect and outcom processing. neuro- 
psychologia 50, 1252e1266. 

doyle, o.m., westman, e., marquand, a.f., mecocci, p., vellas, b., tsolaki, m., 
k1oszewska, i., soininen, h., lovestone, s., williams, s.c.r., simmons, a., 2014. 
predict progress of alzheimer’ diseas use ordin regression. plo 
one 9, e105542. 

eskildsen, s.f., coupé, p., garcía-lorenzo, d., fonov, v., pruessner, j.c., collins, d.l., 
2013. predict of alzheimer’ diseas in subject with mild cognit 
impair from the adni cohort use pattern of cortic thinning. neuro- 
imag 65, 511e521. 

ewers, m., insel, p., jagust, w.j., shaw, l., trojanowski, j.q., aisen, p., petersen, r.c., 
schuff, n., weiner, m.w., 2012. csf biomark and pib-pet-deriv beta-amy- 
loid signatur predict metabolic, gray matter, and cognit chang in non- 
dement subjects. cereb. cortex 22, 1993e2004. 

fagan, a.m., mintun, m.a., mach, r.h., lee, s.-y., dence, c.s., shah, a.r., larossa, g.n., 
spinner, m.l., klunk, w.e., mathis, c.a., dekosky, s.t., morris, j.c., 

http://predictalz.tnlmcgill.ca/predictalz_ami 
http://www.fnih.org 
http://dx.doi.org/10.1016/j.neurobiolaging.2017.06.027 
http://dx.doi.org/10.1016/j.neurobiolaging.2017.06.027 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref1 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref1 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref1 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref1 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref1 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref1 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref2 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref2 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref2 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref2 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref2 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref3 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref3 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref3 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref4 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref4 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref5 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref5 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref5 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref5 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref5 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref6 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref6 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref6 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref6 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref6 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref7 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref7 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref7 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref7 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref8 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref8 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref8 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref8 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref8 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref9 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref9 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref9 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref9 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref10 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref10 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref10 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref11 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref11 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref11 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref11 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref12 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref12 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref12 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref12 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref12 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref13 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref13 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref13 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref13 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref14 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref14 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref14 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref14 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref15 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref15 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref15 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref15 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref15 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref15 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref16 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref16 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref16 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref16 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref16 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref17 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref17 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref17 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref17 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref17 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref18 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref18 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref18 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref18 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref18 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref19 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref19 


S. mathotaarachchi et al. / neurobiolog of age xxx (2017) 1e11 11 
holtzman, d.m., 2006. invers relat between in vivo amyloid imag load 
and cerebrospin fluid abeta42 in humans. ann. neurol. 59, 512e519. 

ferry, a.t., ongür, d., an, x., price, j.l., 2000. prefront cortic project to the 
striatum in macaqu monkeys: evid for an organ relat to pre- 
frontal networks. J. comp. neurol. 425, 447e470. 

fonov, v., evans, a., mckinstry, r., almli, c., collins, d., 2009. unbias nonlinear 
averag age-appropri brain templat from birth to adulthood. neuroimag 
47, s102. 

frome a., sha f., singer y., malik j., sha f., malik j., learn globally-consist local 
distanc function for shape-bas imag retriev and classification, in: com- 
puter vision, 2007. iccv 2007. ieee 11th intern confer on ieee, pp. 
1e8. http://dx.doi.org/10.1109/iccv.2007.4408839. 

fu, h., ng, m.k., nikolova, m., barlow, j.l., 2006. effici minim method of 
mix l2-l1 and l1-l1 norm for imag restoration. siam J. sci. comput. 27, 
1881e1902. 

gaser, c., franke, k., klöppel, s., koutsouleris, n., sauer, h., 2013. brainag in mild 
cognit impair patients: predict the convers to alzheimer’ disease. 
plo one 8, e67346. 

gelosa, g., brooks, d., 2012. the prognost valu of amyloid imaging. eur. J. nucl. 
med. mol. imag 39, 1207e1219. 

hall, a., mattila, j., koikkalainen, j., lötjonen, j., wolz, r., scheltens, p., frisoni, g., 
tsolaki, m., nobili, f., freund-levi, y., minthon, l., frölich, l., hampel, h., 
visser, p.j., soininen, h., 2015. predict progress from cognit impair 
to alzheimer’ diseas with the diseas state index. curr. alzheim res. 12, 
69e79. 

hatashita, s., yamasaki, h., 2013. diagnos mild cognit impair due to 
alzheimer’ diseas with pet biomark of beta amyloid and neuron 
dysfunction. plo one 8, e66877. 

holland, d., mcevoy, l.k., desikan, r.s., dale, a.m., 2012. enrich and 
stratif for predementia alzheim diseas clinic trials. plo one 7, 
e47739. 

huttunen, h., manninen, t., kauppi, j.-p., tohka, j., 2012. mind read with regu- 
lariz multinomi logist regression. mach. vis. appl. 24, 1311e1325. 

ishibashi, k., ishiwata, k., toyohara, j., murayama, s., ishii, k., 2014. region analysi 
of striatal and cortic amyloid deposit in patient with alzheimer’ disease. 
eur. J. neurosci. 40, 2701e2706. 

jack, c.r., knopman, d.s., jagust, w.j., petersen, r.c., weiner, m.w., aisen, p.s., 
shaw, l.m., vemuri, p., wiste, h.j., weigand, s.d., lesnick, t.g., pankratz, v.s., 
donohue, m.c., trojanowski, j.q., 2013. track pathophysiolog process in 
alzheimer’ disease: an updat hypothet model of dynam biomarkers. 
lancet neurol. 12, 207e216. 

jack, c.r., knopman, d.s., jagust, w.j., shaw, l.m., aisen, p.s., weiner, m.w., 
petersen, r.c., trojanowski, j.q., 2010a. hypothet model of dynam bio- 
marker of the alzheimer’ patholog cascade. lancet neurol. 9, 119e128. 

jack, c.r., wiste, h.j., vemuri, p., weigand, s.d., senjem, m.l., zeng, g., 
bernstein, m.a., gunter, j.l., pankratz, v.s., aisen, p.s., weiner, m.w., 
petersen, r.c., shaw, l.m., trojanowski, j.q., knopman, d.s., 2010b. brain beta- 
amyloid measur and magnet reson imag atrophi both predict 
time-to-progress from mild cognit impair to alzheimer’ disease. 
brain 133, 3336e3348. 

japkowicz, n., stephen, s., 2002. the class imbal problem: a systemat study. 
intell. data anal. 6, 429e449. 

jeni, l.a., cohn, j.f., De La torre, f., 2013. face imbalanc dataerecommend 
for the use of perform metrics. 2013 hum. assoc. conf. affect. comput. 
intell. interact 245e251. 

koikkalainen, j., lötjönen, j., thurfjell, l., rueckert, d., waldemar, g., soininen, h., 
2011. multi-templ tensor-bas morphometry: applic to analysi of 
alzheimer’ disease. neuroimag 56, 1134e1144. 

koivunen, j., scheinin, n., virta, j.r., aalto, s., vahlberg, t., nagren, k., 
helin, s., parkkola, r., viitanen, m., rinne, j.o., någren, k., helin, s., 
parkkola, r., viitanen, m., rinne, j.o., 2011. amyloid pet imag in pa- 
tient with mild cognit impairment: a 2-year follow-up study. 
neurolog 76, 1085e1090. 

lebedev, a.v., westman, e., van westen, g.j.p., kramberger, m.g., lundervold, a., 
aarsland, d., soininen, h., k1oszewska, i., mecocci, p., tsolaki, m., vellas, b., 
lovestone, s., simmons, a., 2014. random forest ensembl for detect and 
predict of alzheimer’ diseas with a good between-cohort robustness. 
neuroimag clin. 6, 115e125. 

markesbery, w.r., 2010. neuropatholog alter in mild cognit impairment: 
a review. J. alzheimer’ dis. 19, 221e228. 

mathotaarachchi, s., wang, s., shin, m., pascoal, t.a., benedet, a.l., kang, m.s., 
beaudry, t., fonov, v.s., gauthier, s., labbe, a., rosa-neto, p., 2016. voxelstats: a 
matlab packag for multi-mod voxel-wis brain imag analysis. front. 
neuroinform 10, 20. 

mazziotta, j.c., toga, a.w., evans, a., fox, p., lancaster, j., 1995. A probabilist atla of 
the human brain: theori and rational for it development. the intern 
consortium for brain map (icbm). neuroimag 2, 89e101. 

mcevoy, l.k., brewer, j.b., 2010. quantit structur mri for earli detect of 
alzheimer’ disease. expert rev. neurother. 10, 1675e1688. 

misra, c., fan, y., davatzikos, c., 2009. baselin and longitudin pattern of brain 
atrophi in mci patients, and their use in predict of short-term convers to 
ad: result from adni. neuroimag 44, 1415e1422. 

mitchell, a.j., shiri-feshki, m., 2009. rate of progress of mild cognit impair- 
ment to dementiaemeta-analysi of 41 robust incept cohort studies. acta 
psychiatr. scand. 119, 252e265. 
moradi, e., pepe, a., gaser, c., huttunen, h., tohka, j., 2015. machin learn 
framework for earli mri-bas alzheimer’ convers predict in mci sub- 
jects. neuroimag 104, 398e412. 

morris, j.c., roe, c.m., grant, e.a., head, d., storandt, m., goate, a.m., fagan, a.m., 
holtzman, d.m., mintun, m.a., 2009. pittsburgh compound B imag and 
predict of progress from cognit normal to symptomat alzheim 
disease. arch. neurol. 66, 1469e1475. 

mosconi, l., brys, m., glodzik-sobanska, l., De santi, s., rusinek, h., de leon, m.j., 
2007. earli detect of alzheimer’ diseas use neuroimaging. exp. gerontol. 
42, 129e138. 

ongür, d., price, j.l., 2000. the organ of network within the orbit and 
medial prefront cortex of rats, monkey and humans. cereb. cortex 10, 
206e219. 

petersen, r.c. (ed.), 2003. mild cognit impairment: age to alzheimer’ disease. 
oxford univers press, oxford. 

pouryamout, l., dams, j., wasem, j., dodel, r., neumann, a., 2012. econom eval- 
uation of treatment option in patient with alzheimer’ disease: a systemat 
review of cost-effect analyses. drug 72, 789e802. 

querbes, o., aubry, f., pariente, j., lotterie, j.-a., démonet, j.-f., duret, v., puel, m., 
berry, i., fort, j.-c., celsis, p., 2009. earli diagnosi of alzheimer’ diseas use 
cortic thickness: impact of cognit reserve. brain 132, 2036e2047. 

ranginwala, n.a., hynan, l.s., weiner, m.f., white, c.l., 2008. clinic criterion for the 
diagnosi of alzheim disease: still good after all these years. am. J. geriatr. 
psychiatri 16, 384e388. 

retico, a., bosco, p., cerello, p., fiorina, e., chincarini, a., fantacci, m.e., 2015. pre- 
dictiv model base on support vector machines: whole-brain versu region 
analysi of structur mri in the alzheimer’ disease. J. neuroimag 25, 
552e563. 

robbins, s., evans, a.c., collins, d.l., whitesides, s., 2004. tune and compar 
spatial normal methods. med. imag anal. 8, 311e323. 

schreiber, s., landau, s.m., fero, a., schreiber, f., jagust, w.j., 2015. comparison of 
visual and quantit florbetapir F 18 positron emiss tomographi analysi 
in predict mild cognit impair outcomes. jama neurol. 72, 
1183e1190. 

seiffert, c., khoshgoftaar, t.m., van hulse, j., napolitano, a., 2008. rusboost: 
improv classif perform when train data be skewed. in: 2008 
19th intern confer on pattern recognition. ieee, pp. 1e4. 

seiffert, c., khoshgoftaar, t.m., van hulse, j., napolitano, a., 2010. rusboost: a 
hybrid approach to allevi class imbalance. ieee trans. syst. man. cybern. 
part A syst. human 40, 185e197. 

sled, j.g., zijdenbos, a.p., evans, a.c., 1998. A nonparametr method for automat 
correct of intens nonuniform in mri data. ieee trans. med. imag 17, 
87e97. 

smith, s.m., 2002. fast robust autom brain extraction. hum. brain mapp. 17, 
143e155. 

teipel, s.j., kurth, j., krause, b., grothe, m.j., 2015. the rel import of im- 
age marker for the predict of alzheimer’ diseas dementia in mild 
cognit impair - beyond classic regression. neuroimag clin. 8, 
583e593. 

trzepacz, p.t., yu, p., sun, j., schuh, k., case, m., witte, m.m., hochstetler, h., hake, a., 
2014. comparison of neuroimag modal for the predict of convers 
from mild cognit impair to alzheimer’ dementia. neurobiol. age 35, 
143e151. 

waragai, m., okamura, n., furukawa, k., tashiro, m., furumoto, s., funaki, y., 
kato, m., iwata, r., yanai, k., kudo, y., arai, h., 2009. comparison studi of am- 
yloid pet and voxel-bas morphometri analysi in mild cognit impair 
and alzheimer’ disease. J. neurol. sci. 285, 100e108. 

westman, e., muehlboeck, j.-s., simmons, a., 2012. combin mri and csf mea- 
sure for classif of alzheimer’ diseas and predict of mild cognit 
impair conversion. neuroimag 62, 229e238. 

wolk, d.a., price, j.c., saxton, j.a., snitz, b.e., james, j.a., lopez, o.l., aizenstein, h.j., 
cohen, a.d., weissfeld, l.a., mathis, c.a., klunk, w.e., de-kosky, s.t., 
dekoskym, s.t., 2009. amyloid imag in mild cognit impair subtypes. 
ann. neurol. 65, 557e568. 

wolz, r., julkunen, v., koikkalainen, j., niskanen, e., zhang, d.p., rueckert, d., 
soininen, h., lötjönen, j., 2011. multi-method analysi of mri imag in earli 
diagnost of alzheimer’ disease. plo one 6, e25446. 

wolz, r., schwarz, a.j., gray, k.r., yu, p., hill, d.l.g. alzheimer’ diseas neuro- 
imag initiative, 2016. enrich of clinic trial in mci due to AD use 
marker of amyloid and neurodegeneration. neurolog 87, 1235e1241. 

yang, x., tan, m.z., qiu, a., 2012. csf and brain structur imag marker of the 
alzheimer’ patholog cascade. plo one 7, e47406. 

ye, j., farnum, m., yang, e., verbeeck, r., lobanov, v., raghavan, n., novak, g., 
dibernardo, a., narayan, v.a., 2012. spars learn and stabil select for 
predict mci to AD convers use baselin adni data. bmc neurol. 12, 46. 

yen, s.j., lee, y.s., 2009. cluster-bas under-sampl approach for imbalanc 
data distributions. expert syst. appl. 36, 5718e5727. 

young, j., modat, m., cardoso, m.j., ashburner, j., ourselin, s., 2012. classif of 
alzheimer’ diseas patient and control with gaussian processes. 2012 9th 
ieee int. symp. biomed. imag 1523e1526. 

zhang, d., shen, d., 2012. predict futur clinic chang of mci patient use 
longitudin and multimod biomarkers. plo one 7, e33182. 

zijdenbos, a.p., forghani, r., evans, a.c., 2002. automat “pipeline” analysi of 3-d 
mri data for clinic trials: applic to multipl sclerosis. ieee trans. med. 
imag 21, 1280e1291. 

http://refhub.elsevier.com/s0197-4580(17)30229-4/sref19 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref19 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref19 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref20 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref20 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref20 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref20 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref21 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref21 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref21 
http://dx.doi.org/10.1109/iccv.2007.4408839 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref23 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref23 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref23 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref23 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref24 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref24 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref24 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref25 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref25 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref25 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref26 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref26 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref26 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref26 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref26 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref26 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref27 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref27 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref27 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref28 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref28 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref28 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref29 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref29 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref29 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref30 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref30 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref30 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref30 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref31 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref31 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref31 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref31 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref31 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref31 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref32 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref32 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref32 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref32 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref33 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref33 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref33 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref33 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref33 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref33 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref33 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref34 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref34 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref34 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref35 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref35 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref35 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref35 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref35 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref36 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref36 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref36 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref36 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref37 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref37 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref37 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref37 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref37 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref37 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref38 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref38 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref38 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref38 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref38 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref38 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref38 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref39 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref39 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref39 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref72 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref72 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref72 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref72 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref40 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref40 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref40 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref40 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref41 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref41 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref41 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref42 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref42 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref42 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref42 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref43 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref43 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref43 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref43 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref43 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref44 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref44 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref44 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref44 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref45 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref45 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref45 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref45 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref45 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref46 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref46 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref46 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref46 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref47 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref47 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref47 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref47 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref48 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref48 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref49 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref49 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref49 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref49 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref50 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref50 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref50 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref50 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref51 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref51 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref51 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref51 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref52 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref52 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref52 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref52 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref52 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref53 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref53 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref53 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref54 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref54 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref54 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref54 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref54 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref55 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref55 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref55 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref55 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref56 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref56 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref56 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref56 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref57 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref57 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref57 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref57 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref58 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref58 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref58 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref59 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref59 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref59 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref59 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref59 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref60 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref60 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref60 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref60 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref60 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref61 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref61 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref61 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref61 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref61 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref62 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref62 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref62 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref62 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref63 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref63 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref63 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref63 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref63 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref64 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref64 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref64 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref65 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref65 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref65 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref65 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref66 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref66 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref67 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref67 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref67 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref68 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref68 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref68 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref69 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref69 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref69 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref69 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref70 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref70 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref71 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref71 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref71 
http://refhub.elsevier.com/s0197-4580(17)30229-4/sref71 

identifi incipi dementia individu use machin learn and amyloid imag 
1. introduct 
2. materi and method 
2.1. subject and data acquisit 
2.2. imag process 
2.3. subject classif 
2.4. featur select 
2.5. predict 
2.6. perform evalu and comparison 

3. result 
4. discuss 
disclosur statement 
acknowledg 
appendix A. supplementari data 
refer 


